NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for...( SAN DIEGO April 15 /- NexBio Inc....)

SAN DIEGO, April 15 /PRNewswire/ -- NexBio, Inc. announced today that it has completed the formation of a new Clinical Advisory Board (CAB) to complement its existing group of Senior Advisers. NexBio recently completed a First-In-Man clinical trial of DAS181 (Fludase(R)), an investigational drug candidate for influenza. The new CAB will guide NexBio throughout the clinical development of this novel medicine, helping the company to conduct advanced product development to address the threat of a potential influenza pandemic. The CAB is chaired by Andrew Pavia, M.D., who is joined by Robert Belshe, M.D., Kathryn Edwards, M.D., Allison McGeer, M.D., FRCPC, and Richard Whitley, M.D.

"These individuals are among the most highly regarded thought leaders in the field of clinical development of drugs for respiratory viral infections," said Ron Moss, M.D., NexBio's Executive Vice President, Clinical Development & Medical Affairs. "We expect that their depth of knowledge and experience will contribute enormously to the goal of developing Fludase for the prevention and treatment of Influenza-Like Illness caused by influenza, parainfluenza, and potential pandemic strains such as H5N1. With the development of drug resistance to currently licensed antivirals, our distinguished CAB recognizes the importance of determining the clinical utility of DAS181 against emerging strains of influenza."

Dr. Pavia is the George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases at the University of Utah Health Sciences Center. He is very active as an infectious disease investigator and in policy. Dr. Pavia serves on several advisory committees for federal and state government on vaccine policy, biodefense, and pandemic influenza preparedness. He leads several committees of the Infectious Diseases Society of America and has been a member of the Institute of Medicine C
'/>"/>